Related Experiment Video
Updated: Jul 17, 2026

14:10
Protocol for Plasmodium falciparum Infections in Mosquitoes and Infection Phenotype Determination
Published on: July 4, 2007
Histoplasmosis: a clinical and laboratory update
1Infectious Diseases Division, Department of Internal Medicine, Ann Arbor Veterans Affairs Healthcare System, University of Michigan Medical School, Ann Arbor, MI, USA. ckauff@umich.edu
Clinical Microbiology Reviews
|January 16, 2007
Summary
Histoplasma capsulatum infection is common in certain regions, but severe disease is rare. Diagnosis and treatment have advanced, with azoles like itraconazole being preferred for mild to moderate histoplasmosis.
Area of Science:
- Mycology
- Infectious Diseases
- Immunology
Background:
- Histoplasma capsulatum infection is endemic in the Midwestern US and Central America.
- Symptomatic disease is infrequent, with severity dependent on inhaled dose and host immunity.
- Pulmonary infection ranges from mild pneumonitis to severe respiratory distress.
Purpose of the Study:
- To review the clinical manifestations, diagnosis, and treatment of histoplasmosis.
- To highlight advancements in diagnostic accuracy and therapeutic strategies.
Main Methods:
- Review of existing literature on Histoplasma capsulatum.
- Analysis of diagnostic methods including antigen assays, serology, and culture.
- Evaluation of current treatment guidelines and drug efficacy.
Main Results:
- Histoplasmosis presents primarily as pulmonary infection, but dissemination can occur, especially in immunocompromised individuals.
- Urine antigen assays improve diagnostic accuracy.
- Amphotericin B is reserved for severe cases, with azoles, particularly itraconazole, being the preferred treatment for mild to moderate disease.
Conclusions:
- Histoplasmosis management has evolved, emphasizing early diagnosis and targeted therapy.
- Itraconazole is a key agent in treating various forms of histoplasmosis.
- Understanding host immune function is critical for predicting disease severity.
Related Concept Videos
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
